Martek, Infant Formula Trade Groups Urge FDA To Drop Label Study
This article was originally published in The Tan Sheet
Executive Summary
Infant formula industry stakeholders largely reject FDA's proposal for studying consumer understanding of and response to label statements on formula products.
You may also be interested in...
In Brief
C&D may cover costs by raising prices
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.